During the past decade, The Sakakibara Heart Institute of Okayama conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Sakakibara Heart Institute of Okayama" #1 sponsor was "Bayer" with 2 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Sakakibara Heart Institute of Okayama" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic Japan Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "The Sakakibara Heart Institute of Okayama" are "Coronary Artery Disease" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Heart Failure" (1 trials). Many other conditions were trialed in "The Sakakibara Heart Institute of Okayama" in a lesser frequency.

Most popular intervention types in "The Sakakibara Heart Institute of Okayama" are "Device" (7 trials), "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Aspirin" (2 trials), "Thienopyridine" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Sakakibara Heart Institute of Okayama" are 12 trials for "All" genders.

Currently, there are NaN active trials in "The Sakakibara Heart Institute of Okayama". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Sakakibara Heart Institute of Okayama, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Sakakibara Heart Institute of Okayama, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".